(Total Views: 131)
Posted On: 08/21/2025 3:48:42 PM
Post# of 96
Illumina–Bionano collaboration
The integration of Bionano’s Optical Genome Mapping (OGM) data with Illumina’s Next-Generation Sequencing (NGS) workflows marks a pivotal moment in genomics. This isn’t just a technical upgrade, it’s a strategic alignment that could finally crack the institutional resistance from big pharma and legacy sequencing platforms.
Bionano’s VIA and Solve software platforms now support integrated analysis of OGM, microarray, and NGS data, bringing together different kinds of genetic tests so doctors can spot problems more quickly and accurately.
Labs using Illumina’s NGS platforms can now incorporate Bionano’s OGM without overhauling their existing infrastructure, making adoption smoother and more scalable.
Illumina’s endorsement of Bionano’s tech, even indirectly, adds credibility and visibility. It positions Bionano as a complementary player, not a competitor, in the genomics ecosystem.
The integration of Bionano’s Optical Genome Mapping (OGM) data with Illumina’s Next-Generation Sequencing (NGS) workflows marks a pivotal moment in genomics. This isn’t just a technical upgrade, it’s a strategic alignment that could finally crack the institutional resistance from big pharma and legacy sequencing platforms.
Bionano’s VIA and Solve software platforms now support integrated analysis of OGM, microarray, and NGS data, bringing together different kinds of genetic tests so doctors can spot problems more quickly and accurately.
Labs using Illumina’s NGS platforms can now incorporate Bionano’s OGM without overhauling their existing infrastructure, making adoption smoother and more scalable.
Illumina’s endorsement of Bionano’s tech, even indirectly, adds credibility and visibility. It positions Bionano as a complementary player, not a competitor, in the genomics ecosystem.
(0)
(0)
